Costs of payment in Thai acute coronary syndrome patients

Journal of the Medical Association of Thailand

Volumn 90, Issue SUPPL 1, 2007, Pages 21-31

  Moleerergpoom, Worachat ^a   Kanjanavanit, Rungsrit ^b   Jintapakorn, Woravut ^c   Sritara, Piyamitr ^d  

^a POLICE GENERAL HOSPITAL   (Thailand)

^b Maharaj Nakorn Chiang Mai Hospital   (Thailand)

^c Songklanagarind Hospital   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acute coronary syndrome; Costs of payment; Thai ACS registry

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DATA BASE; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; THAILAND; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; DATABASES AS TOPIC; FEMALE; FIBRINOLYTIC AGENTS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; THAILAND;

EID: 43849086497     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Anukoolaswat P, Sritara P. Costs of lifetime acute coronary syndrome treatment at Ramathibodi hospital [abstract]. Presented at Annual Meeting of Thai Heart Association of Thailand. Bangkok, Thailand; 2006.
2. Piyasirisilp N, Sritara P, Tangchareonsathien V, Yamwong S, Cheepudomwit S. Hospital cost of acute coronary syndrome in Ramathibodi Hospital, 2002-2003. Thai Heart J 2004; 17: 67-75.
3. Eisenstein EL, Shaw LK, Anstrom KJ, Nelson CL, Hakim Z, Hasselblad V, et al. Assessing the clinical and economic burden of coronary artery disease: 1986-1998. Med Care 2001; 39: 824-35.
4. Russell MW, Huse DM, Drowns S, Hamel EC, Hartz SC. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998; 81: 1110-5.
5. Nagle PC, Smith AW. Review of recent US cost estimates of revascularization. Am J Manag Care 2004; 10(11 Suppl): S370-S376.
6. McCollam P, Etemad L. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization. J Invasive Cardiol 2005; 17: 307-11.
7. Cohen DJ, O'Shea JC, Pacchiana CM, Levine G, Sarembock I, Slater J, et al. In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. Am J Cardiol 2002; 89: 61-4.
8. Bakhai A, Stone GW, Grines CL, Murphy SA, Githiora L, Berezin RH, et al. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. Circulation 2003; 108: 2857-63.
9. Brown RE, Henderson RA, Koster D, Hutton J, Simoons ML. Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The platelet IIa/IIb in unstable angina: receptor suppression using integrilin therapy. Eur Heart J 2002; 23: 50-8.
10. van Hout BA, Serruys PW, Lemos PA, van den Brand MJ, van Es GA, Lindeboom WK, et al. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart 2005; 91: 507-12.
11. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
12. Lieu TA, Gurley RJ, Lundstrom RJ, Ray GT, Fireman BH, Weinstein MC, et al. Projected costeffectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1997; 30: 1741-50.
13. Machecourt J, Bonnefoy E, Vanzetto G, Motreff P, Marliere S, Leizorovicz A, et al. Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: the comparison of angioplasty and pre-hospital thrombolysis in acute myocardial infarction (CAPTIM) cost-efficacy sub-study. J Am Coll Cardiol 2005; 45: 515-24.
14. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-87.
15. FRagmin and Fast Revascularisation during instability in coronary artery disease investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999; 354: 708-15.
16. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002; 23: 1177-89.
17. Mahoney EM, Jurkovitz CT, Chu H, Becker ER, Culler S, Kosinski AS, et al. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA 2002; 288: 1851-8.
18. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994; 89: 1545-56.
19. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/ American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002; 40: 1366-74.
20. Mark DB, Lee TH. Conservative management of acute coronary syndrome: cheaper and better for you? Circulation 2002; 105: 666-8.
21. Etemad LR, McCollam PL. Predictors of high-cost managed care patients with acute coronary syndrome. Curr Med Res Opin 2005; 21: 1977-84.
22. Kuntz KM, Tsevat J, Goldman L, Weinstein MC. Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation 1996; 94: 957-65.